Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 135.95 Delayed Data As of 3:59pm ET |  -0.61 / -0.45%Today’s Change | 61.28 Today|||52-Week Range 159.84 | +4.92% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $11.5B |
Company Description
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Contact Information
Sarepta Therapeutics, Inc. 215 First Street Cambridge Massachusetts 02142 |
Employees
Shareholders
| Individual stakeholders | 5.32% |
| Mutual fund holders | 45.47% |
| Other institutional | 43.42% |
Top Executives
| Douglas S. Ingram | President, Chief Executive Officer & Director |
| Ian M. Estepan | Executive VP, Chief Financial & Accounting Officer |
| Louise Rodino-Klapac | Chief Scientific Officer & Executive VP |
| Bilal Arif | Chief Technical Operations Officer & Executive VP |
| Diane Berry | EVP, Chief Global Policy & Advocacy Officer |
